Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Chronic Kidney Diseases

fluorodeoxyglucose f18 has been researched along with Chronic Kidney Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Kang, L; Su, T; Wang, H; Wang, S; Yang, L1
Hoogeveen, RM; Kaiser, Y; Kroon, J; Moens, SJB; Stroes, ESG; Verberne, HJ; Verweij, SL; Vogt, L1
Bhowmik, D; Brijwal, M; Damle, NA; Das, CJ; Kumari, K; Singh, G; Swamy, A1
Blake, GM; Compston, JE; Fogelman, I; Frost, ML; Goldsmith, D; Moore, AE; Siddique, M; Skingle, L1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Chronic Kidney Diseases

ArticleYear
Diffuse large B cell lymphoma in a preceding IgG4-related disease with kidney restricted lambda light chain expression: case report and literature review.
    BMC nephrology, 2020, 07-29, Volume: 21, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Missed Diagnosis; Nephritis, Interstitial; Positron Emission Tomography Computed Tomography; Prednisone; Radiopharmaceuticals; Renal Insufficiency, Chronic

2020

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Chronic Kidney Diseases

ArticleYear
Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease.
    Scientific reports, 2021, 02-18, Volume: 11, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Female; Fluorodeoxyglucose F18; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Renal Insufficiency, Chronic; Risk Factors

2021
The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.
    Kidney international, 2019, Volume: 95, Issue:4

    Topics: Allografts; Biopsy; BK Virus; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Graft Rejection; Humans; Immunosuppression Therapy; Kidney; Kidney Neoplasms; Kidney Transplantation; Middle Aged; Polyomavirus Infections; Positron Emission Tomography Computed Tomography; Renal Insufficiency, Chronic; Tumor Virus Infections

2019
(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.
    Calcified tissue international, 2013, Volume: 93, Issue:5

    Topics: Adult; Aged; Bone Density; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteogenesis; Positron-Emission Tomography; Renal Dialysis; Renal Insufficiency, Chronic

2013